anti-Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antikörper

CIITA encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. Zusätzlich bieten wir Ihnen Class II, Major Histocompatibility Complex, Transactivator Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
CIITA 12265 P79621
CIITA 4261 P33076
CIITA 85483  
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Class II, Major Histocompatibility Complex, Transactivator Antikörper auf antikoerper-online.de

Showing 10 out of 46 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis of extracts from K562 cells, using CIITA Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 6 bis 8 Tage
342,86 €
Details
Rind (Kuh) Kaninchen Unkonjugiert WB 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
358,51 €
Details
Human Kaninchen Unkonjugiert IP   0.1 mL Anmelden zum Anzeigen 7 bis 9 Tage
495,00 €
Details
Schwein Kaninchen Unkonjugiert WB Western blot of Anti-CIITA (1-333) antibody, generated by immunization with bacterially produced DYKDDDDK-CIITA aa 1-333, was tested by western blot against lysates of Cos-7 cells after transient transfection, separately, with pcDNA3-DYKDDDDK-CIITA-336-884 and pcDNA3-HA-CIITA. For transfection, Fugene 6 (Roche) was used according to the manufacturer's instructions for a 6-well plate format. Cells were lysed 24 h post-transfection in 200 uL of 1x SDS-sample buffer, heated at 96C for 5', and vortexed for 30 sec. Samples (10 uL each) were separated on a 12% SDS-PAGE gel and transferred to PVDF (Millipore) followed by blocking for 45' using TTBS supplemented with 5% non-fat dry milk. All incubations were performed at room temperature. In panel A, both samples on PVDF were incubated with 10 ug/mL mouse anti-DYKDDDDK antibody (Sigma) for 45'. After 5X washes with TTBS, reaction with ALP rabbit anti-mouse IgG at 200 ng/mL proceeded for 45' following again by washing as before. The blot was developed using BCIP/NBT. This blot demonstrates that DYKDDDDK-CIITA-336-842 was successfully over-expressed in the Cos-7 cells. In panel B, both samples on PVDF were incubated with a 1:500 dilution of anti-CIITA (1-333) for 45'. After 5X washes with TTBS, reaction with HRP goat anti-rabbit IgG at 10 ng/mL proceeded for 45' following again by washing as before. The membrane was covered with Pico West Substrate solution (Pierce) for 5' and was then placed between the two layers of a standard sheet protector. Kodak O-MAT film was exposed to the blot for 30 sec and was immediately developed. The lane containing the lysate of pcDNA3-HA-CIITA transfected cells contains a single band at ~130 kD molecular weight, whereas the lane containing lysate from pcDNA3-DYKDDDDK-CIITA-336-842 transfected cells shows no reactivity. This blot demonstrates that anti-CIITA (1-333) is specific for amino acids 1-333 of CIITA and that the antibody is not cross reactive with the DYKDDDDK portion of the immunogen. 100 μL Anmelden zum Anzeigen 5 bis 7 Tage
412,76 €
Details
Human Kaninchen Unkonjugiert EIA, IP, WB   0.1 mg Anmelden zum Anzeigen 7 bis 9 Tage
495,00 €
Details
Hund Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 11 bis 14 Tage
653,02 €
Details
Human Kaninchen Unkonjugiert IHC (p), WB   100 μg Anmelden zum Anzeigen 8 bis 11 Tage
340,48 €
Details
Rind (Kuh) Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 11 bis 14 Tage
653,02 €
Details
Human Kaninchen Unkonjugiert WB Western blot (WB) analysis of CIITA antibody in extracts from K562 cells. 0.1 mg Anmelden zum Anzeigen 7 bis 9 Tage
385,00 €
Details
Human Kaninchen Unkonjugiert EIA, IP, WB   0.1 mL Anmelden zum Anzeigen 6 bis 8 Tage
391,60 €
Details

CIITA Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität
Mouse (Murine)


Human , , ,
,
,
Rat (Rattus)


Am meisten referenzierte anti-Class II, Major Histocompatibility Complex, Transactivator Antikörper

  1. Human Polyclonal CIITA Primary Antibody für ELISA, WB - ABIN1533701 : Steimle, Otten, Zufferey, Mach: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). in Cell 1993 (PubMed)

  2. Pig (Porcine) Polyclonal CIITA Primary Antibody für WB - ABIN97339 : Koues, Dudley, Mehta, Greer: The 19S proteasome positively regulates histone methylation at cytokine inducible genes. in Biochimica et biophysica acta 2009 (PubMed)

  3. Human Polyclonal CIITA Primary Antibody für EIA, IP - ABIN116528 : Inouye, Delihas: Small RNAs in the prokaryotes: a growing list of diverse roles. in Cell 1988 (PubMed)

Weitere Antikörper gegen Class II, Major Histocompatibility Complex, Transactivator Interaktionspartner

Mouse (Murine) Class II, Major Histocompatibility Complex, Transactivator (CIITA) Interaktionspartner

  1. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC (zeige MSC Antikörper) implantation on myocardial repair.

  2. M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK (zeige MAPK14 Antikörper) activation

  3. this study shows that genetic polymorphisms in the type I promoter of C2ta regulate MHC-II expression and T-cell responses but do not necessarily have a strong impact on autoimmune diseases

  4. CIITA interacted with and recruited PRMT5 to the MHC II promoter and mediated the synergy between PRMT5 and ASH2/WDR5 to activate MHC II transcription

  5. NLRC5 (zeige NLRC5 Antikörper) and CIITA thus emerge as paradigms for a novel class of transcriptional regulators dedicated for transactivating extremely few, phylogenetically related genes.

  6. Data suggest that class II transactivator CIITA expression is likely mediated in hematopoietic cells by common elements with promoter accessibility having a part in promoter choice.

  7. Transfection of CIITA in poorly immunogenic PDA cells resulted in increased expression levels of the MHC class II molecule. CIITA-tumor cells were rejected in 80% to 100% of injected mice.

  8. IFN-gamma exerts a critical anti-inflammatory function in the intestine which protects against colitis by inducing MHCII expression on intestinal epithelial cells.

  9. tumor cell lines with a defective expression of CIITA transcripts lack MHC class II expression

  10. study provides compelling genetic evidence that CIITA, the molecular switch of antigen presentation, plays a novel, unexpected function in skeletal homeostasis, independent of MHC Class II expression and T cells

Human Class II, Major Histocompatibility Complex, Transactivator (CIITA) Interaktionspartner

  1. B. abortus lipoproteins via IL-6 (zeige IL6 Antikörper) inhibit the expression of IFN regulatory factor 1 (IRF-1 (zeige IRF1 Antikörper)), a critical regulatory transcription factor for CIITA induction.

  2. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC (zeige MSC Antikörper) implantation on myocardial repair.

  3. Brazilian Amerindian ancestry compared to Asian, European, and African Genomes.SNPs within or proximal to CIITA (rs6498115), SMC6 (zeige SMC6 Antikörper) (rs1834619), and KLHL29 (rs2288697) were most differentiated in the Amerindian-specific branch. SNPs in ADAMTS9 (zeige ADAMTS9 Antikörper) (rs7631391), DOCK2 (zeige DOCK2 Antikörper) (rs77594147), SLC28A1 (rs28649017), ARHGAP5 (zeige ARHGAP5 Antikörper) (rs7151991), and CIITA (rs45601437) in the Asian comparison.

  4. CLPTM1L (zeige CLPTM1L Antikörper) and TERT (zeige TERT Antikörper) have been implicated in cancers, and CIITA is considered as the "master control factor" for the expression of NPC (zeige NPC1 Antikörper)-associated MHC class II (zeige HLA-DPA1 Antikörper) genes. These suggested that both SNPs might be functional. Altogether, our findings expand our understanding of the genetic contribution to NPC (zeige NPC1 Antikörper) risk and provide novel biological insights into NPC (zeige NPC1 Antikörper) pathogenesis.

  5. When mouse pDCs and CAL-1 cells were stimulated by GM-CSF, mRNA levels of PU.1, pIII-driven CIITA, total CIITA, MHC class II, and the amount of PU.1 binding to pIII were significantly increased

  6. the MHC2TA -168 A/G polymorphism is not associated with susceptibility to rheumatoid arthritis in Caucasians [meta-analysis]

  7. Observed no association between the MHC2TA or FCRL3 (zeige FCRL3 Antikörper) SNPs and rheumatoid arthritis in Mexican patients.

  8. CIITA acts as a general restriction factor against HIV-1 not only in T cells but also in myeloid cells.

  9. CIITA gene alterations are a common mechanism of immune escape through reduction of MHC class II expression in primary mediastinal large B cell lymphoma.

  10. CIITA Isoform III interacts more efficiently with components of the transcription machinery and MHC-II promoter binding proteins.

Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antigen-Profil

Protein Überblick

This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the 'master control factor' for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction.

Genbezeichner und Symbole assoziert mit CIITA

  • class II, major histocompatibility complex, transactivator (CIITA) Antikörper
  • class II, major histocompatibility complex, transactivator (ciita) Antikörper
  • class II transactivator (Ciita) Antikörper
  • class II, major histocompatibility complex, transactivator (Ciita) Antikörper
  • C2TA Antikörper
  • CIITA Antikörper
  • CIITAIV Antikörper
  • EG669998 Antikörper
  • Gm9475 Antikörper
  • Mhc2ta Antikörper
  • NLRA Antikörper

Bezeichner auf Proteinebene für CIITA

class II, major histocompatibility complex, transactivator , class II transactivator-like , class II transactivator , MHC class II transactivator-like , MHC class II transactivator , MHC class II transactivator type III , NLR family, acid domain containing , nucleotide-binding oligomerization domain, leucine rich repeat and acid domain containing , MHC class II transactivator type IV

GENE ID SPEZIES
427676 Gallus gallus
453914 Pan troglodytes
508720 Bos taurus
710761 Macaca mulatta
100003537 Danio rerio
100056546 Equus caballus
100338894 Oryctolagus cuniculus
100402996 Callithrix jacchus
100443575 Pongo abelii
12265 Mus musculus
100736732 Sus scrofa
4261 Homo sapiens
85483 Rattus norvegicus
490008 Canis lupus familiaris
Ausgewählte Anbieter für anti-Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antikörper
Haben Sie etwas anderes gesucht?